Aging-US-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-05-13 ms3000000640673488 来自河南省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的

5 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-04-16 ms1000000039072412 来自甘肃省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤学
经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。

18 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-05-22 ms8000000649093531 来自佐治亚

已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-05-22 ms6000001249379532 来自湖北省

审稿速度:6.0
偏重的研究方向：肿瘤;生信
经验分享：一审67天，大修，12天后修回，二审37天后接收

5 0

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-05-01 ms6000001249379532 来自湖北省

审稿速度:3.0
偏重的研究方向：肿瘤;生信
经验分享：大修二审要多久呀，已经16天了.......

12 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-02-11 ms9000000336595833 来自山东省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;生信
经验分享：初审2个月左右，然后直接小修后接受，美滋滋

0 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-03-23 biocell160 来自贵州省

under review，第9天，求点顺利接收了的大佬们的运气！

18 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2023-12-19 ms6000000741257643 来自广西

审稿速度:3.0 | 投稿命中率:75.0
经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投

26 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2022-03-29 Jessy-feng

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：代谢
经验分享：今早收到接收邮件
提交：2022-1-19
under review: 2022-1-22
processing decision: 2022-2-12
decision send back to author: 2022-2-15(小修)
提交：2022-3-20
Initial QC: 2022-3-20
under review:2022-3-24
processing decision:2022-3-25
accept:2022-3-29

53 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204346, encodeId=678d220434656, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志似乎刻意延长从投稿到接收的时间，看发表的文章，基本都经历六个月左右，但也有个别两个月就接收的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a19196066, createdName=ms3000000640673488, createdTime=Mon May 13 08:33:34 CST 2024, time=2024-05-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198749, encodeId=39ae2198e49f3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：2023年11月20日投稿，一审3个月，中间催稿一次，后给大修。大修时间给了5个月，大概一个半月返回。返回后7天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba685590129, createdName=ms1000000039072412, createdTime=Tue Apr 16 09:59:27 CST 2024, time=2024-04-16, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2206106, encodeId=aea5220610630, content=已经接受2周了，还不能在PUBMED检索到，大概要等多久啊大佬们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97938396728, createdName=ms8000000649093531, createdTime=Wed May 22 21:01:41 CST 2024, time=2024-05-22, status=1, ipAttribution=佐治亚), GetPortalCommentsPageByObjectIdResponse(id=2206044, encodeId=17c32206044ce, content=审稿速度:6.0 偏重的研究方向：肿瘤;生信 经验分享：一审67天，大修，12天后修回，二审37天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 22 17:42:57 CST 2024, time=2024-05-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2201392, encodeId=cb7d2201392b5, content=审稿速度:3.0 偏重的研究方向：肿瘤;生信 经验分享：大修二审要多久呀，已经16天了......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d67e8287749, createdName=ms6000001249379532, createdTime=Wed May 01 19:36:19 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186902, encodeId=1605218690298, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：初审2个月左右，然后直接小修后接受，美滋滋, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4678995909, createdName=ms9000000336595833, createdTime=Sun Feb 11 12:23:31 CST 2024, time=2024-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194803, encodeId=f2bf2194803ae, content=under review，第9天，求点顺利接收了的大佬们的运气！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Sat Mar 23 00:58:03 CST 2024, time=2024-03-23, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2175958, encodeId=017b21e5958eb, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审3个月还没有结果，发邮件也不回，坑的要死，急的话慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1668197286, createdName=ms6000000741257643, createdTime=Tue Dec 19 20:45:51 CST 2023, time=2023-12-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1206813, encodeId=019f120681321, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：代谢 经验分享：今早收到接收邮件 提交：2022-1-19 under review: 2022-1-22 processing decision: 2022-2-12 decision send back to author: 2022-2-15(小修) 提交：2022-3-20 Initial QC: 2022-3-20 under review:2022-3-24 processing decision:2022-3-25 accept:2022-3-29, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=735a5560271, createdName=Jessy-feng, createdTime=Tue Mar 29 09:17:58 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193313, encodeId=a4482193313ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：小修，半个月接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59409076927, createdName=ms8000001769686032, createdTime=Fri Mar 15 09:07:14 CST 2024, time=2024-03-15, status=1, ipAttribution=天津)]

2024-03-15 ms8000001769686032 来自天津

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：小修，半个月接收！

23 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务